Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.17996 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.09338 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.09693 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.99473 | 45 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.03119 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.24636 | 48 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.18612 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.06379 | 46 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.03334 | 45 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.05158 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.09042 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.02844 | 45 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.1096 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.0901 | 47 |